Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine

NCT02332954 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: vortioxetine

Sponsor

Lundbeck Canada Inc.